Javascript must be enabled to continue!
Effects of Dexmedetomidine on Oxidative Stress, Inflammatory Response, Coagulation Function and Hemodynamics in Patients Undergoing Hysterectomy
View through CrossRef
<i>Objective</i> To investigate the effects of dexmedetomidine on oxidative stress, inflammatory response, coagulation function and hemodynamics in patients undergoing hysterectomy. <i>Methods</i> 92 patients who underwent hysterectomy in our hospital from January to September 2023 were selected as subjects. According to the difference in anesthesia, 46 patients were in the control group and 46 in the dexmedetomidine group. Patients in the control group received midazolam anesthesia, and patients in the dexmedetomidine group received dexmedetomidine anesthesia. The changes of oxidative stress, inflammatory response, coagulation function and hemodynamics were compared between T0 (before anesthesia), T1 (10 min after anesthesia), T2 (after extubation) and T3 (24 h after surgery). <i>Results</i> At T0, there was no significant difference in T-AOC, GSH-Px, MBP, MCP-1, AT III, FDP, MAP and SpO<sub>2</sub> between the two groups (<I>P</I>>0.05). At the time of T1, T2 and T3, the two groups of patients T-AOC, GSH-Px were all lower than T0 (<I>P</I><0.05), MBP and MCP-1 were all higher than T0 (<I>P</I><0.05). The levels of T-AOC and GSH-Px in the dexmedetomidine group were significantly higher than those in the control group (<I>P</I><0.05). The levels of MCP-1 was significantly lower than that of the control group (<I>P</I><0.05). At the T1 and T2, ATIII levels was lower than T0 (<I>P</I><0.05), and FDP levels was higher than T0 (<I>P</I><0.05). At the time of T3, the levels of ATIII and FDP in the dexmedetomidine group recovered to the normal level of T0. There was no significant change in MAP and SpO<sub>2</sub> at each time in the dexmedetomidine group (<I>P</I>>0.05). <i>Conclusion</i> Dexmedetomidine can more effectively alleviate the oxidative stress response in patients with hysterectomy, reduce the symptoms of inflammation in patients, improve the coagulation status of patients and have less influence on hemodynamics, and have high clinical value.
Science Publishing Group
Title: Effects of Dexmedetomidine on Oxidative Stress, Inflammatory Response, Coagulation Function and Hemodynamics in Patients Undergoing Hysterectomy
Description:
<i>Objective</i> To investigate the effects of dexmedetomidine on oxidative stress, inflammatory response, coagulation function and hemodynamics in patients undergoing hysterectomy.
<i>Methods</i> 92 patients who underwent hysterectomy in our hospital from January to September 2023 were selected as subjects.
According to the difference in anesthesia, 46 patients were in the control group and 46 in the dexmedetomidine group.
Patients in the control group received midazolam anesthesia, and patients in the dexmedetomidine group received dexmedetomidine anesthesia.
The changes of oxidative stress, inflammatory response, coagulation function and hemodynamics were compared between T0 (before anesthesia), T1 (10 min after anesthesia), T2 (after extubation) and T3 (24 h after surgery).
<i>Results</i> At T0, there was no significant difference in T-AOC, GSH-Px, MBP, MCP-1, AT III, FDP, MAP and SpO<sub>2</sub> between the two groups (<I>P</I>>0.
05).
At the time of T1, T2 and T3, the two groups of patients T-AOC, GSH-Px were all lower than T0 (<I>P</I><0.
05), MBP and MCP-1 were all higher than T0 (<I>P</I><0.
05).
The levels of T-AOC and GSH-Px in the dexmedetomidine group were significantly higher than those in the control group (<I>P</I><0.
05).
The levels of MCP-1 was significantly lower than that of the control group (<I>P</I><0.
05).
At the T1 and T2, ATIII levels was lower than T0 (<I>P</I><0.
05), and FDP levels was higher than T0 (<I>P</I><0.
05).
At the time of T3, the levels of ATIII and FDP in the dexmedetomidine group recovered to the normal level of T0.
There was no significant change in MAP and SpO<sub>2</sub> at each time in the dexmedetomidine group (<I>P</I>>0.
05).
<i>Conclusion</i> Dexmedetomidine can more effectively alleviate the oxidative stress response in patients with hysterectomy, reduce the symptoms of inflammation in patients, improve the coagulation status of patients and have less influence on hemodynamics, and have high clinical value.
Related Results
Incidence of Fever Associated With Dexmedetomidine in the Adult Intensive Care Unit
Incidence of Fever Associated With Dexmedetomidine in the Adult Intensive Care Unit
Background:
Published literature has described the temporal relationship of dexmedetomidine with elevated temperatures, but there is limited data to quantify th...
A Comparative Study of Dexmedetomidine-Fentanyl Versus Dexmedetomidine-Pentazocine for Monitored Anesthesia Care in Tympanoplasty
A Comparative Study of Dexmedetomidine-Fentanyl Versus Dexmedetomidine-Pentazocine for Monitored Anesthesia Care in Tympanoplasty
Background: Monitored anesthesia care (MAC) is increasingly being used in various surgical procedures due to its safety and effectiveness. Tympanoplasty, a common otological proced...
Comparison of Intravenous Sedation with Dexmedetomidine and Propofol for Breast Cancer Skin Lesion Electrochemotherapy: A Randomized, Double‐blinded Clinical Trial
Comparison of Intravenous Sedation with Dexmedetomidine and Propofol for Breast Cancer Skin Lesion Electrochemotherapy: A Randomized, Double‐blinded Clinical Trial
Background: Skin metastases occur in 5% - 30% of breast cancer patients, highlighting the need for effective treatments. Electrochemotherapy, which combines electric pulses with ch...
Renoprotective effects Of Dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats
Renoprotective effects Of Dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats
Abstract
Background
Diabetic patients are susceptible to renal ischemia-reperfusion injury, which leads to perioperative compli...
Does the intraperitoneal dexmedetomidine induce bone regeneration in cranial defects at subsedative doses in rabbits?
Does the intraperitoneal dexmedetomidine induce bone regeneration in cranial defects at subsedative doses in rabbits?
Objective:
Dexmedetomidine has been shown to exert protective
and curative effects on various tissues and organs in different
pathological processes. This study a...
Hysterectomy and mental health status, findings from Ardakan Cohort Study on Aging (ACSA)
Hysterectomy and mental health status, findings from Ardakan Cohort Study on Aging (ACSA)
Abstract
Background
Many middle-aged and older women have undergone hysterectomy in their lifetime. The mental health outcomes of hysterectomy are controversial. This stud...
Nasal and Intravenous Administration of Dexmedetomidine to Prevent the Emergence Agitation After the Vascular Interventional Surgery in Children: A Randomized, Double-blind, Controlled Study
Nasal and Intravenous Administration of Dexmedetomidine to Prevent the Emergence Agitation After the Vascular Interventional Surgery in Children: A Randomized, Double-blind, Controlled Study
Abstract
Introduction: Dexmedetomidine reduces the incidences of postanesthetic restlessness and hemodynamic fluctuations in children within acceptable ranges. Dexmedetomid...
Efficacy of Dexmedetomidine for Reduction of Emergency Delirium in Children Undergoing Tonsillectomy in CMH Muzaffarabad AJK
Efficacy of Dexmedetomidine for Reduction of Emergency Delirium in Children Undergoing Tonsillectomy in CMH Muzaffarabad AJK
Background: Emergency delirium (ED) is a common and distressing complication in children recovering from anesthesia, particularly after tonsillectomy. Dexmedetomidine, a selective ...

